Breaking News on Contract Research, Manufacturing & Clinical Trials

News in brief

NextPharma doubles blister capacity

28-Jan-2009

Related topics: Contract Manufacturing

NextPharma Technologies has doubled the Alu Alu blister packaging capacity at its facility for Cephalosporins in Göttingen, Germany.

The increase takes total capacity up to 18m blisters a year and has been achieved through the installation of a second flexible Alu/Alu blister-line.

Bill Wedlake, CEO of NextPharma, said: “We’re aware of the rising requirement for this packaging technology and are pleased to be in a position to meet market demands.”

Follow us on

Key Industry Events

Partnerships in Clinical Trials

Orlando, FL 32821 / Conference

Read more

Procurecon Pharma 2012

Zurich-Glattpark, 8152 / Conference and exhibition

Read more

Access our events listing